Which of the following antimicrobials should not be given to a chronic asthmatic patient managed on theophylline therapy?
**Core Concept**
Theophylline is a methylxanthine medication used in the management of asthma. It is metabolized by the cytochrome P450 enzyme system, particularly by CYP1A2. Certain antimicrobials can induce or inhibit this enzyme system, thereby affecting theophylline levels and increasing the risk of toxicity.
**Why the Correct Answer is Right**
Ciprofloxacin is a fluoroquinolone antibiotic that is known to be a potent inhibitor of CYP1A2. By inhibiting this enzyme, ciprofloxacin can increase theophylline levels, leading to toxicity in patients managed on theophylline therapy. This is particularly concerning in patients with chronic asthma, where theophylline is used to control symptoms. The increased theophylline levels can exacerbate respiratory symptoms and worsen asthma control.
**Why Each Wrong Option is Incorrect**
**Option A:** Erythromycin is a macrolide antibiotic that can induce CYP3A4, but it does not significantly affect theophylline levels. Therefore, it is not the correct answer.
**Option B:** Amoxicillin is a penicillin antibiotic that does not significantly interact with theophylline. It is not the correct answer.
**Option C:** Metronidazole is an antibiotic that does not significantly interact with theophylline. It is not the correct answer.
**Clinical Pearl / High-Yield Fact**
When managing patients on theophylline therapy, it is essential to consider potential interactions with other medications, particularly antibiotics. Always review the patient's medication list and consider the potential for drug interactions before prescribing any new medication.
**Correct Answer: D. Ciprofloxacin**